Paolo Blasi

5.1k total citations · 2 hit papers
92 papers, 4.0k citations indexed

About

Paolo Blasi is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Paolo Blasi has authored 92 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmaceutical Science, 21 papers in Biomaterials and 20 papers in Molecular Biology. Recurrent topics in Paolo Blasi's work include Advanced Drug Delivery Systems (28 papers), Advancements in Transdermal Drug Delivery (16 papers) and Drug Solubulity and Delivery Systems (14 papers). Paolo Blasi is often cited by papers focused on Advanced Drug Delivery Systems (28 papers), Advancements in Transdermal Drug Delivery (16 papers) and Drug Solubulity and Delivery Systems (14 papers). Paolo Blasi collaborates with scholars based in Italy, United States and Austria. Paolo Blasi's co-authors include Maurizio Ricci, Stefano Giovagnoli, Aurélie Schoubben, Carlo Riccardo Rossi, Barbara Bellich, A. Rampino, Massimiliano Borgogna, Attilio Cesàro, Patrick P. DeLuca and Francesca Selmin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Paolo Blasi

91 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chitosan nanoparticles: Preparation, size evolution and stability

2013 483 citations Paolo Blasi et al. International Journal of Pharmaceutics profile →
Surfactant Self-Assembling and Critical Micelle Concentration: One Approach Fits All?

2020 220 citations Diego Romano Perinelli, Marco Cespi et al. profile →

Peers

Countries citing papers authored by Paolo Blasi

Since Specialization

Citations

This map shows the geographic impact of Paolo Blasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Blasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Blasi more than expected).

Fields of papers citing papers by Paolo Blasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Blasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Blasi. The network helps show where Paolo Blasi may publish in the future.

Co-authorship network of co-authors of Paolo Blasi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Blasi. A scholar is included among the top collaborators of Paolo Blasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Blasi. Paolo Blasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Collaborative innovation during the drug discovery and development process 2025 ·Drug Discovery Today ·Xue Wu, Mirjam Knockaert, Paolo Blasi	2
2	Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells 2024 ·Pharmaceutics ·(unknown), (unknown), (unknown), Aikaterini Andreadi, Francesca Borsetti, (unknown), (unknown), Martina Rossi, Giovanna Farruggia, Paolo Blasi, Isabella Orienti	1
3	Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models 2024 ·Biomedicine & Pharmacotherapy ·Michela Rossi, C. Pellegrino, (unknown), Giovanna Farruggia, Dario de Biase, Silvia Cetrullo, Sarah D’Adamo, Alessandra Bisi, Paolo Blasi, Emil Malucelli, Concettina Cappadone, Silvia Gobbi	3
4	Small-angle X-ray scattering unveils the internal structure of lipid nanoparticles 2024 ·Journal of Colloid and Interface Science ·Francesco Spinozzi, Paolo Moretti, Diego Romano Perinelli, (unknown), (unknown), Heinz Amenitsch, (unknown), Giancarlo Franzese, Paolo Blasi	15
5	Effect of Cocoa Roasting on Chocolate Polyphenols Evolution 2023 ·Antioxidants ·(unknown), Federica Ianni, Aurélie Schoubben, Marco Cespi, Klemen Lisjak, (unknown), Roccaldo Sardella, Paolo Blasi	8
6	In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents 2022 ·International Journal of Molecular Sciences ·Simone Di Micco, Veronica Di Sarno, Martina Rossi, Vincenzo Vestuto, Takumi Konno, (unknown), Mario Felice Tecce, (unknown), Tania Ciaglia, Andrea Vitale, Isabel Gómez‐Monterrey, Gennaro Nicola Bifulco, Alessia Bertamino, Carmine Ostacolo, Paolo Blasi, Alessio Fasano, Pietro Campiglia, Simona Musella	10
7	Ketoprofen poly(lactide-co-glycolide) physical interaction studied by Brillouin spectroscopy and molecular dynamics simulations 2020 ·International Journal of Pharmaceutics ·Paolo Blasi, (unknown), Alessandro Pedretti, D. Fioretto, Giulio Vistoli, S. Corezzi	7
8	Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright? 2015 ·Current Pharmaceutical Design ·Stefano Giovagnoli, Giovanni Luca, Paolo Blasi, Francesca Mancuso, Aurélie Schoubben, Iva Arato, Mario Calvitti, (unknown), Giuseppe Basta, Maria Bodo, Riccardo Calafiore, Maurizio Ricci	21
9	Capreomycin inhalable powders prepared with an innovative spray-drying technique 2014 ·International Journal of Pharmaceutics ·Aurélie Schoubben, Stefano Giovagnoli, Maria Cristina Tiralti, Paolo Blasi, Maurizio Ricci	29
10	Evaluation ofIn VitroCytoxicity and Genotoxicity of Size-Fractionated Air Particles Sampled during Road Tunnel Construction 2013 ·BioMed Research International ·Luca Dominici, (unknown), Milena Villarini, Cristina Fatigoni, Massimo Moretti, Paolo Blasi, Silvano Monarca	8
11	Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity 2013 ·International Journal of Pharmaceutics ·Paolo Blasi, Aurélie Schoubben, Giovanna Traina, Giuseppe Manfroni, (unknown), Paolo Alberti, (unknown), Maurizio Ricci	44
12	Capreomycin supergenerics for pulmonary tuberculosis treatment: Preparation, in vitro, and in vivo characterization 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·Aurélie Schoubben, Paolo Blasi, Maria Luisa Marenzoni, (unknown), Stefano Giovagnoli, (unknown), Maurizio Ricci	37
13	Effect of Agitation Regimen on the in vitro Release of Leuprolide from Poly(Lactic-Co-Glycolic) Acid Microparticles 2011 ·Journal of Pharmaceutical Sciences ·Aurélie Schoubben, Paolo Blasi, Patrick P. DeLuca	17
14	Simple and scalable method for peptide inhalable powder production 2009 ·European Journal of Pharmaceutical Sciences ·Aurélie Schoubben, Paolo Blasi, Stefano Giovagnoli, Maurizio Ricci, Carlo Riccardo Rossi	20
15	Influence of Compression Force on The Behavior of Mucoadhesive Buccal Tablets 2008 ·AAPS PharmSciTech ·Luana Perioli, Valeria Ambrogi, Stefano Giovagnoli, Paolo Blasi, Alessandra Mancini, Maurizio Ricci, Carlo Riccardo Rossi	14
16	Plasticizing effect of water on poly(lactide-co-glycolide) 2005 ·Journal of Controlled Release ·Paolo Blasi, Susan D’Souza, Francesca Selmin, Patrick P. DeLuca	261
17	Ketoprofen controlled release from composite microcapsules for cell encapsulation: Effect on post-transplant acute inflammation 2005 ·Journal of Controlled Release ·Maurizio Ricci, Paolo Blasi, Stefano Giovagnoli, Carlo Riccardo Rossi, (unknown), Giovanni Luca, Giuseppe Basta, Riccardo Calafiore	76
18	Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: In vitro effects on isolated neonatal porcine pancreatic cell clusters 2005 ·Journal of Controlled Release ·Stefano Giovagnoli, Giovanni Luca, Ivan Casaburi, Paolo Blasi, (unknown), Maurizio Ricci, Mario Calvitti, Giuseppina Basta, Riccardo Calafiore, Carlo Riccardo Rossi	47
19	Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery 2004 ·AAPS PharmSciTech ·Stefano Giovagnoli, Paolo Blasi, Maurizio Ricci, Carlo Riccardo Rossi	75
20	Unilamellar vesicles as potential capreomycin sulfate carriers: Preparation and physicochemical characterization 2003 ·AAPS PharmSciTech ·Stefano Giovagnoli, Paolo Blasi, (unknown), Giuseppe Fardella, (unknown), Luana Perioli, Maurizio Ricci, Carlo Riccardo Rossi	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact